Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Sanchez

Showing results (241-250 of 319) with videos related to

Pageof 32
Sort By:
AIDS Research and Human Retroviruses|September 22, 2010
Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy AdultsOuzama Nicholson, Fay DiCandilo, James Kublin, et al.
Translational Vision Science & Technology|September 4, 2020
Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic RetinopathyCarlos D Nuñez-Amaro, Aura Ileana Moreno-Vega, Elva Adan-Castro, et al.
Clinical and Translational Allergy|November 30, 2025
Evaluation of the Quality and Reliability of ChatGPT-4's Responses on Allergen Immunotherapy Using Validated Instruments for Health Information Quality AssessmentIvan Cherrez-Ojeda, Torsten Zuberbier, Gabriela Rodas-Valero, et al.
Annals of the Rheumatic Diseases|May 19, 2023
Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experienceJoo-Young E Lee, Arielle Mendel, Anca Askanase, et al.
The Journal of Infectious Diseases|January 10, 2014
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particlesPaul A Goepfert, Marnie L Elizaga, Kelly Seaton, et al.
Mabs|August 13, 2025
Building a potent TREM2 agonistic, biparatopic, common light chain antibodyAna da Silva Almeida, Melissa L Geddie, Anil Bhate, et al.
Journal of Affective Disorders|October 10, 2025
Acid accumulation in bipolar disorderAndres Marcelo Trevino-Alvarez, Vanessa Pazdernik, Manuel Gardea-Resendez, et al.
Journal of Virology|April 13, 2012
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacityMark A Brockman, Denis R Chopera, Alex Olvera, et al.
Communications Biology|April 23, 2021
ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillanceSu Chul Jang, Kyriakos D Economides, Raymond J Moniz, et al.
The Lancet. HIV|November 28, 2025
Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trialSusan P Buchbinder, Sabrina Spinosa Guzman, Jorge Sanchez, et al.
Pageof 32

Showing results (241-250 of 319) with videos related to

Sort By:
Pageof 32
AIDS Research and Human Retroviruses|September 22, 2010
Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy AdultsOuzama Nicholson, Fay DiCandilo, James Kublin, et al.
Translational Vision Science & Technology|September 4, 2020
Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic RetinopathyCarlos D Nuñez-Amaro, Aura Ileana Moreno-Vega, Elva Adan-Castro, et al.
Clinical and Translational Allergy|November 30, 2025
Evaluation of the Quality and Reliability of ChatGPT-4's Responses on Allergen Immunotherapy Using Validated Instruments for Health Information Quality AssessmentIvan Cherrez-Ojeda, Torsten Zuberbier, Gabriela Rodas-Valero, et al.
Annals of the Rheumatic Diseases|May 19, 2023
Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experienceJoo-Young E Lee, Arielle Mendel, Anca Askanase, et al.
The Journal of Infectious Diseases|January 10, 2014
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particlesPaul A Goepfert, Marnie L Elizaga, Kelly Seaton, et al.
Mabs|August 13, 2025
Building a potent TREM2 agonistic, biparatopic, common light chain antibodyAna da Silva Almeida, Melissa L Geddie, Anil Bhate, et al.
Journal of Affective Disorders|October 10, 2025
Acid accumulation in bipolar disorderAndres Marcelo Trevino-Alvarez, Vanessa Pazdernik, Manuel Gardea-Resendez, et al.
Journal of Virology|April 13, 2012
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacityMark A Brockman, Denis R Chopera, Alex Olvera, et al.
Communications Biology|April 23, 2021
ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillanceSu Chul Jang, Kyriakos D Economides, Raymond J Moniz, et al.
The Lancet. HIV|November 28, 2025
Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trialSusan P Buchbinder, Sabrina Spinosa Guzman, Jorge Sanchez, et al.
Pageof 32